Collegium Pharmaceutical (COLL) Accumulated Expenses (2014 - 2026)
Collegium Pharmaceutical (COLL) reported Accumulated Expenses of $71.25 million for Q2 2026, up 19.9% from $59.44 million a year earlier and up 22.5% from the prior quarter.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Collegium Pharmaceutical posted Accumulated Expenses of $62.46 million, down 13.4% from FY2024.
- Accumulated Expenses has a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $72.12 million in FY2024 (+92.0%), $37.57 million in FY2023 (+4.0%), $36.13 million in FY2022 (+23.7%) and $29.21 million in FY2021 (+18.5%).
- The Q2 2026 figure ranks as the highest quarterly Accumulated Expenses since Q4 2024.
- Year over year, Accumulated Expenses gained in seven of the last eight quarters, with growth averaging 32.4%.
- The high point for year-over-year Accumulated Expenses in five years was Q1 2022 (growth of 143.1%); the low point was Q1 2023 (a decline of 40.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $58.15 million (Q1 2026), $62.46 million (Q4 2025) and $51.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Collegium Pharmaceutical | 744.00 Mn | -479.76 Mn | 110.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.25 Mn |
| Mar 31, 2026 | 58.15 Mn |
| Dec 31, 2025 | 62.46 Mn |
| Sep 30, 2025 | 51.47 Mn |
| Jun 30, 2025 | 59.44 Mn |
| Mar 31, 2025 | 53.74 Mn |
| Dec 31, 2024 | 72.12 Mn |
| Sep 30, 2024 | 47.60 Mn |
| Jun 30, 2024 | 38.73 Mn |
| Mar 31, 2024 | 38.19 Mn |
| Dec 31, 2023 | 37.57 Mn |
| Sep 30, 2023 | 31.65 Mn |
| Jun 30, 2023 | 35.25 Mn |
| Mar 31, 2023 | 24.43 Mn |
| Dec 31, 2022 | 36.13 Mn |
| Sep 30, 2022 | 22.80 Mn |
| Jun 30, 2022 | 39.70 Mn |
| Mar 31, 2022 | 41.07 Mn |
| Dec 31, 2021 | 29.21 Mn |
| Sep 30, 2021 | 20.59 Mn |
API Access
Collegium Pharmaceutical Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();